The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-cyano-3-(4-(dipentylamino)-2-methoxyphenyl)acrylic acid ID: ALA3582421
PubChem CID: 71667549
Max Phase: Preclinical
Molecular Formula: C21H30N2O3
Molecular Weight: 358.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCN(CCCCC)c1ccc(/C=C(\C#N)C(=O)O)c(OC)c1
Standard InChI: InChI=1S/C21H30N2O3/c1-4-6-8-12-23(13-9-7-5-2)19-11-10-17(20(15-19)26-3)14-18(16-22)21(24)25/h10-11,14-15H,4-9,12-13H2,1-3H3,(H,24,25)/b18-14+
Standard InChI Key: LYZWLUWMPJZUDU-NBVRZTHBSA-N
Molfile:
RDKit 2D
26 26 0 0 0 0 0 0 0 0999 V2000
5.1877 -7.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8999 -0.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1972 -1.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4998 -0.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7972 -1.5212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8387 -0.9251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2948 3.7533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2551 4.3525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8925 3.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8895 4.9584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9334 3.1614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5955 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
6 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 3 0
17 20 1 0
20 21 2 0
20 22 1 0
15 23 1 0
23 24 1 0
24 25 1 0
23 26 2 0
26 12 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.48Molecular Weight (Monoisotopic): 358.2256AlogP: 4.87#Rotatable Bonds: 12Polar Surface Area: 73.56Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.12CX Basic pKa: 4.96CX LogP: 3.24CX LogD: 1.94Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -0.60
References 1. Gurrapu S, Jonnalagadda SK, Alam MA, Nelson GL, Sneve MG, Drewes LR, Mereddy VR.. (2015) Monocarboxylate transporter 1 inhibitors as potential anticancer agents., 6 (5): [PMID:26005533 ] [10.1021/acsmedchemlett.5b00049 ] 2. (2016) Therapeutic compounds, 3. Puri S, Juvale K.. (2020) Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights., 199 [PMID:32388280 ] [10.1016/j.ejmech.2020.112393 ]